#medicine

Phase III trial results reported in the New England Journal of Medicine showed roughly one in five chronic hepatitis B patients achieved a functional cure after 24 weeks of bepirovirsen.

After years of limited treatment options, kidney disease research is moving into a more active phase, with targeted therapies ranging from immunomodulators to genetically defined drugs.

Researchers say personalized ‘digital brain twins’ are emerging as data-driven models that could help predict disease, test treatments, and simulate brain function without direct risk to patients.

A new paper has linked Wegovy to ischemic optic neuropathy, sometimes called an eye stroke, but experts say the evidence is preliminary and the overall rate reported so far remains very low.

Scientists led by Nanyang Technological University, Singapore, report that proteins found in urine can predict which dengue patients are more likely to progress to severe disease, opening the door to simpler risk triage.

Doctors in Germany report that a CAR-T treatment sent three severe autoimmune diseases into sustained remission in a 47-year-old woman after years of failed therapies.

A large UK trial found that women’s HRT patches treated prostate cancer as effectively as standard hormone injections while reducing some of the worst side effects.

A new study links heavy electronic paperwork burdens to higher burnout risk among young doctors, adding to concerns that digital administration is reshaping clinical work.